ModivCare Inc. (MODV)
USD 1.29
(13.16%)
USD 1.29
(13.16%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.14 Billion USD | 11.65% |
| 2022 | 1.02 Billion USD | 0.14% |
| 2021 | 1.01 Billion USD | 96.94% |
| 2020 | 517.73 Million USD | 2298.61% |
| 2019 | 21.58 Million USD | 1915.41% |
| 2018 | 1.07 Million USD | -64.11% |
| 2017 | 2.98 Million USD | -17.36% |
| 2016 | 3.61 Million USD | -98.81% |
| 2015 | 303.84 Million USD | -47.18% |
| 2014 | 575.21 Million USD | 365.76% |
| 2013 | 123.5 Million USD | -5.0% |
| 2012 | 130 Million USD | -13.62% |
| 2011 | 150.49 Million USD | -17.45% |
| 2010 | 182.3 Million USD | -10.73% |
| 2009 | 204.21 Million USD | -14.11% |
| 2008 | 237.75 Million USD | -3.12% |
| 2007 | 245.41 Million USD | 25704.78% |
| 2006 | 951.05 Thousand USD | -94.81% |
| 2005 | 18.32 Million USD | 1513.92% |
| 2004 | 1.13 Million USD | -70.29% |
| 2003 | 3.82 Million USD | -73.67% |
| 2002 | 14.51 Million USD | -98.58% |
| 2001 | 1.02 Billion USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.14 Billion USD | 0.82% |
| 2024 Q2 | 1.21 Billion USD | 5.33% |
| 2023 Q3 | 1.1 Billion USD | -3.63% |
| 2023 Q1 | 1.03 Billion USD | 1.67% |
| 2023 Q4 | 1.14 Billion USD | 2.9% |
| 2023 FY | 1.14 Billion USD | 11.65% |
| 2023 Q2 | 1.14 Billion USD | 10.75% |
| 2022 FY | 1.02 Billion USD | 0.14% |
| 2022 Q1 | 1.02 Billion USD | 0.06% |
| 2022 Q2 | 1.01 Billion USD | -0.04% |
| 2022 Q3 | 1.01 Billion USD | -0.07% |
| 2022 Q4 | 1.02 Billion USD | 0.2% |
| 2021 Q1 | 516.84 Million USD | -0.17% |
| 2021 Q2 | 528.62 Million USD | 2.28% |
| 2021 Q3 | 1.01 Billion USD | 92.83% |
| 2021 FY | 1.01 Billion USD | 96.94% |
| 2021 Q4 | 1.01 Billion USD | 0.03% |
| 2020 Q1 | 182 Million USD | 743.18% |
| 2020 Q3 | 19.84 Million USD | -5.96% |
| 2020 Q2 | 21.1 Million USD | -88.41% |
| 2020 FY | 517.73 Million USD | 2298.61% |
| 2020 Q4 | 517.73 Million USD | 2509.18% |
| 2019 Q4 | 21.58 Million USD | -1.7% |
| 2019 FY | 21.58 Million USD | 1915.41% |
| 2019 Q1 | 23.29 Million USD | 2074.79% |
| 2019 Q2 | 21.2 Million USD | -8.94% |
| 2019 Q3 | 21.95 Million USD | 3.53% |
| 2018 Q2 | 2.22 Million USD | -5.73% |
| 2018 Q3 | 37.57 Million USD | 1591.99% |
| 2018 Q4 | 1.07 Million USD | -97.15% |
| 2018 FY | 1.07 Million USD | -64.11% |
| 2018 Q1 | 2.35 Million USD | -21.05% |
| 2017 Q4 | 2.98 Million USD | 42.5% |
| 2017 Q2 | 3.04 Million USD | 3.67% |
| 2017 FY | 2.98 Million USD | -17.36% |
| 2017 Q1 | 2.94 Million USD | -18.55% |
| 2017 Q3 | 2.09 Million USD | -31.32% |
| 2016 Q3 | 322.89 Million USD | 4.81% |
| 2016 Q4 | 3.61 Million USD | -98.88% |
| 2016 FY | 3.61 Million USD | -98.81% |
| 2016 Q1 | 307.85 Million USD | 1.32% |
| 2016 Q2 | 308.07 Million USD | 0.07% |
| 2015 Q1 | 504.02 Million USD | -12.38% |
| 2015 FY | 303.84 Million USD | -47.18% |
| 2015 Q4 | 303.84 Million USD | -36.97% |
| 2015 Q2 | 488.33 Million USD | -3.11% |
| 2015 Q3 | 482.03 Million USD | -1.29% |
| 2014 Q1 | 123.5 Million USD | 0.0% |
| 2014 Q2 | 191.6 Million USD | 55.14% |
| 2014 FY | 575.21 Million USD | 365.76% |
| 2014 Q4 | 575.21 Million USD | 200.22% |
| 2014 Q3 | 191.6 Million USD | 0.0% |
| 2013 Q1 | 127.25 Million USD | -2.12% |
| 2013 Q4 | 123.5 Million USD | 0.0% |
| 2013 Q3 | 123.5 Million USD | 0.0% |
| 2013 FY | 123.5 Million USD | -5.0% |
| 2013 Q2 | 123.5 Million USD | -2.95% |
| 2012 Q2 | 145.49 Million USD | -1.69% |
| 2012 Q4 | 130 Million USD | -7.47% |
| 2012 FY | 130 Million USD | -13.62% |
| 2012 Q1 | 147.99 Million USD | -1.66% |
| 2012 Q3 | 140.5 Million USD | -3.43% |
| 2011 Q3 | 152.99 Million USD | -8.67% |
| 2011 FY | 150.49 Million USD | -17.45% |
| 2011 Q4 | 150.49 Million USD | -1.63% |
| 2011 Q2 | 167.52 Million USD | -1.46% |
| 2011 Q1 | 170 Million USD | -6.75% |
| 2010 Q1 | 195.59 Million USD | -4.22% |
| 2010 FY | 182.3 Million USD | -10.73% |
| 2010 Q4 | 182.3 Million USD | -1.95% |
| 2010 Q3 | 185.92 Million USD | -1.91% |
| 2010 Q2 | 189.54 Million USD | -3.09% |
| 2009 FY | 204.21 Million USD | -14.11% |
| 2009 Q1 | 234.18 Million USD | -1.5% |
| 2009 Q2 | 230.61 Million USD | -1.53% |
| 2009 Q3 | 227.03 Million USD | -1.55% |
| 2009 Q4 | 204.21 Million USD | -10.05% |
| 2008 FY | 237.75 Million USD | -3.12% |
| 2008 Q4 | 237.75 Million USD | -0.49% |
| 2008 Q3 | 238.93 Million USD | -0.9% |
| 2008 Q2 | 241.09 Million USD | -0.89% |
| 2008 Q1 | 243.25 Million USD | -0.88% |
| 2007 FY | 245.41 Million USD | 25704.78% |
| 2007 Q4 | 245.41 Million USD | 1204.99% |
| 2007 Q2 | 8.1 Million USD | 870.33% |
| 2007 Q1 | 834.96 Thousand USD | -12.21% |
| 2007 Q3 | 18.8 Million USD | 132.12% |
| 2006 Q4 | 951.05 Thousand USD | -4.99% |
| 2006 Q3 | 1 Million USD | -11.06% |
| 2006 Q2 | 1.12 Million USD | -94.28% |
| 2006 FY | 951.05 Thousand USD | -94.81% |
| 2006 Q1 | 19.66 Million USD | 7.31% |
| 2005 Q3 | 19.92 Million USD | 70.91% |
| 2005 Q2 | 11.65 Million USD | 949.31% |
| 2005 Q1 | 1.11 Million USD | -2.14% |
| 2005 Q4 | 18.32 Million USD | -8.04% |
| 2005 FY | 18.32 Million USD | 1513.92% |
| 2004 Q3 | 1.23 Million USD | 1.0% |
| 2004 Q2 | 1.22 Million USD | 1.12% |
| 2004 Q1 | 1.2 Million USD | -68.41% |
| 2004 Q4 | 1.13 Million USD | -7.91% |
| 2004 FY | 1.13 Million USD | -70.29% |
| 2003 Q4 | 3.82 Million USD | -5.36% |
| 2003 FY | 3.82 Million USD | -73.67% |
| 2003 Q3 | 4.03 Million USD | -80.15% |
| 2003 Q2 | 20.34 Million USD | 0.0% |
| 2002 FY | 14.51 Million USD | -98.58% |
| 2001 Q4 | 1.02 Billion USD | 0.0% |
| 2001 FY | 1.02 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 24.535% |
| Addus HomeCare Corporation | 175.18 Million USD | -550.791% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -1043.866% |
| Amedisys, Inc. | 487.21 Million USD | -133.998% |
| American Oncology Network, Inc. | 128.32 Million USD | -788.422% |
| Astrana Health, Inc. | 321.01 Million USD | -255.146% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 23.955% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -892.477% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -10363.15% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -21545.491% |
| COMPASS Pathways plc | 33.04 Million USD | -3349.525% |
| DocGo Inc. | 46.49 Million USD | -2351.91% |
| The Ensign Group, Inc. | 1.87 Billion USD | 39.076% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -2512.737% |
| InnovAge Holding Corp. | 113.03 Million USD | -908.597% |
| Assure Holdings Corp. | 14.8 Million USD | -7600.561% |
| The Joint Corp. | 16.73 Million USD | -6712.545% |
| LifeStance Health Group, Inc. | 511.04 Million USD | -123.087% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -173391.211% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -342722.949% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -25395.472% |
| Option Care Health, Inc. | 1.16 Billion USD | 2.259% |
| P3 Health Partners Inc. | 124.64 Million USD | -814.681% |
| P3 Health Partners Inc. | 124.64 Million USD | -814.681% |
| The Pennant Group, Inc. | 329.63 Million USD | -245.861% |
| Surgery Partners, Inc. | 3.06 Billion USD | 62.762% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -459413.992% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | -851.524% |
| The Oncology Institute, Inc. | 119.81 Million USD | -851.524% |